Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lantheus Holdings (NQ: LNTH )

101.70 -8.06 (-7.35%)
Streaming Delayed Price Updated: 10:20 AM EDT, Jul 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Lantheus Presentations at the European Association of Nuclear Medicine Annual Meeting Showcased Artificial Intelligence Data
From Lantheus Holdings, Inc.
Via GlobeNewswire
How to Find Stocks That Rise 10x
Investors looking for 10X stocks should prioritize companies in high-growth areas that demonstrate high earnings quality. 
Via InvestorPlace
New GE-Backed Heart Disease Study May Advance Detection To Never Before Seen Levels
Via Benzinga
Lantheus's Imaging Agent Can Assess PD-L1 Expression for Immunotherapy In Cancer Patients
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
Upgrades 
Via Benzinga
Levi Strauss, Tilray Brands And Some Other Big Stocks Moving Lower On Friday
U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2022
Upgrades 
Via Benzinga
Payoneer Global Set To Join S&P SmallCap 600
Via Benzinga
Silk Road Medical Stock Scores Relative Strength Rating Upgrade
Silk Road Medical sees its Relative Strength Rating reach the elite 90-plus level. 
Via Investor's Business Daily
7 Momentum Stocks to Buy Now for Extraordinary Gains
Momentum stocks aren't as risky as some say, and these winning stocks are strong examples for investors to consider. 
Via InvestorPlace
Here Is How To Use Relative Strength To Predict The Next Big Move In Tesla
According to the relative strength comparison together with the bullish price structure, Tesla (TSLA) could be brewing for a big move ahead. 
Via Talk Markets
Here Is How To Pick Winning Stocks To Outperform In A Bear Market Or Market Correction
Here is the exact blueprint you need to follow to pick the winning stocks and the next multi-baggers in a bear market or market correction. 
Via Talk Markets
3 Small-Cap Stocks That Could 10X by 2027
If you’re looking for a 10-fold increase in your investment, forgo large caps, and look to these three small-cap stocks to buy. 
Via InvestorPlace
Top-Rated Stocks: Lantheus Stock Sees Composite Rating Climb To 96
Top-rated Lantheus stock saw an improvement in its IBD SmartSelect Composite Rating Thursday, from 94 to 96. 
Via Investor's Business Daily
Lantheus Holdings Earnings Perspective: Return On Capital Employed
According to Benzinga Pro, during Q2, Lantheus Holdings (NASDAQ:LNTH) earned $43.06 million, a 0.22% increase from the preceding quarter. Lantheus Holdings also posted a total of $223.72 million in... 
Via Benzinga
Glaukos Stock Scores Rising Price Performance With Jump To 91 RS Rating
On Tuesday, Glaukos stock hit an key technical milestone, with its Relative Strength Rating climbing to 91, up from 87 the day before. 
Via Investor's Business Daily
This Company Reports Moving Toward FDA Approval To Provide Pain-Free Diabetes Monitoring
Caused predominantly by genetic predisposition, immune disorders and other factors, such as unhealthy diet and exercise habits, diabetes is one of the most common lifelong chronic diseases in the... 
Via Benzinga
iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday
U.S. stocks closed mixed on Friday following the release of jobs data for July. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
These Were The Five Best And Worst Performing Mid-Cap Stocks In H1 2022
Investors who want to make quick returns while having some stability amid the current volatile market environment can go for mid-cap stocks. Let’s take a look at the five best and worst performing... 
Via Talk Markets
Silk Road Medical Stock Clears Key Benchmark, Hitting 90-Plus RS Rating
Silk Road Medical stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 69 to 90. 
Via Investor's Business Daily
Why Jim Cramer Says This Stock Is 'Now A Little Over-Valued'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Lantheus Holdings Inc (NASDAQ: LNTH) has been a "rocket ship, but it’s now a little over-valued." 
Via Benzinga
Nasdaq Flashes A Stealth Buy Signal: What’s Next?
The Nasdaq is now trading above its 20-day exponential moving average. 
Via Talk Markets
7 Best Fidelity ETFs to Buy in July
July may be a great time to check out the best Fidelity ETFs, as some top names are currently for sale at bargain valuations. 
Via InvestorPlace
UnitedHealth, Shockwave Lead 5 Healthy Stocks Breaking Out Or Setting Up
Shockwave and UnitedHealth lead 5 stocks that are setting up or breaking out. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Redhill Biopharma (NASDAQ:RDHL) stock moved upwards by 16.4% to $0.89 during Friday's pre-market session. The market value of their outstanding shares is at $47.6 million. As per the press... 
Via Benzinga
7 Hot Stocks to Buy During the Next Market Crash
These aren't likely the stocks you think about when you think about hot stocks, but that's what makes them so special. 
Via InvestorPlace
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Lantheus Holdings Doses First Patient in Phase 2 Clinical Trial of NM-01 for NSCLC
Lantheus Holdings, Inc. (NASDAQ: LNTH) dosed first patient in a Phase 2 trial evaluating NM-01, its proprietary technetium 99m SPECT imaging agent used to assess PD-L1 expression in cancer cells. NM-01... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022
Upgrades 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.